1. Home
  2. OPRA vs TARS Comparison

OPRA vs TARS Comparison

Compare OPRA & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPRA
  • TARS
  • Stock Information
  • Founded
  • OPRA 1996
  • TARS 2016
  • Country
  • OPRA Norway
  • TARS United States
  • Employees
  • OPRA N/A
  • TARS N/A
  • Industry
  • OPRA Computer Software: Prepackaged Software
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • OPRA Technology
  • TARS Health Care
  • Exchange
  • OPRA Nasdaq
  • TARS Nasdaq
  • Market Cap
  • OPRA 1.4B
  • TARS 1.7B
  • IPO Year
  • OPRA 2018
  • TARS 2020
  • Fundamental
  • Price
  • OPRA $17.01
  • TARS $69.09
  • Analyst Decision
  • OPRA Strong Buy
  • TARS Strong Buy
  • Analyst Count
  • OPRA 5
  • TARS 7
  • Target Price
  • OPRA $24.90
  • TARS $67.14
  • AVG Volume (30 Days)
  • OPRA 804.0K
  • TARS 737.2K
  • Earning Date
  • OPRA 10-28-2025
  • TARS 11-12-2025
  • Dividend Yield
  • OPRA 4.65%
  • TARS N/A
  • EPS Growth
  • OPRA N/A
  • TARS N/A
  • EPS
  • OPRA 0.90
  • TARS N/A
  • Revenue
  • OPRA $554,721,000.00
  • TARS $295,521,000.00
  • Revenue This Year
  • OPRA $26.28
  • TARS $137.28
  • Revenue Next Year
  • OPRA $14.72
  • TARS $42.84
  • P/E Ratio
  • OPRA $19.95
  • TARS N/A
  • Revenue Growth
  • OPRA 29.84
  • TARS 254.45
  • 52 Week Low
  • OPRA $12.83
  • TARS $32.91
  • 52 Week High
  • OPRA $22.50
  • TARS $69.49
  • Technical
  • Relative Strength Index (RSI)
  • OPRA 41.34
  • TARS 77.06
  • Support Level
  • OPRA $18.39
  • TARS $56.25
  • Resistance Level
  • OPRA $21.06
  • TARS $59.78
  • Average True Range (ATR)
  • OPRA 0.98
  • TARS 2.58
  • MACD
  • OPRA -0.29
  • TARS 1.15
  • Stochastic Oscillator
  • OPRA 7.02
  • TARS 97.60

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: